/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Manisha H. Shah

Liaquat National Hospital(PK)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

325

Papers

33.6K

Citations

63

h-index

162

i10-index

Manisha H. Shah is an academic researcher from Liaquat National Hospital. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Thyroid Cancer Diagnosis and Treatment. The author has an h-index of 63, co-authored 277 publications.

ORCID: 0000-0002-6453-2044

Research Topics

Neuroendocrine Tumor Research Advances Lung Cancer Research Studies Thyroid Cancer Diagnosis and Treatment Neuroblastoma Research and Treatments Cancer Immunotherapy and Biomarkers

Papers by this author

works

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

2011 · New England Journal of Medicine · 2,831 citations

https://doi.org/10.1056/nejmoa1009290

James C. Yao Manisha H. Shah Tetsuhide Ito C. Lombard Bohas

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

2020 · The Lancet Oncology · 2,390 citations

https://doi.org/10.1016/s1470-2045(20)30445-9

Aurélien Marabelle Marwan Fakih Juanita Lopez Manisha H. Shah

Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response

1999 · The Journal of Immunology · 639 citations

https://doi.org/10.4049/jimmunol.162.8.4511

Todd A. Fehniger Manisha H. Shah Matthew J. Turner Jeffrey VanDeusen

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

2017 · Endocrine · 102 citations

https://doi.org/10.1007/s12020-017-1233-5

Robert I. Haddad Martin Schlumberger Lori J. Wirth Eric J. Sherman

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

2016 · Investigational New Drugs · 63 citations

https://doi.org/10.1007/s10637-016-0336-9

Manisha H. Shah Paul Lorigan Mary O’Brien Frank V. Fossella

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer

2024 · The Journal of Clinical Endocrinology & Metabolism · 9 citations

https://doi.org/10.1210/clinem/dgae512

Bhavana Konda Eric J. Sherman Erminia Massarelli Jorge J. Nieva

Research topics

topics

Neuroendocrine Tumor Research Advances

Lung Cancer Research Studies

Thyroid Cancer Diagnosis and Treatment

Neuroblastoma Research and Treatments

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat